Bringing Innovative Diagnostics to the U.S. Market
NeoMark Ventures is the experienced U.S. commercial partner for international diagnostic manufacturers seeking to enter and expand in the American healthcare market.
How We Help
We guide international diagnostic manufacturers through every stage of U.S. market entry — from strategy through commercialization.
U.S. Market-Entry Strategy
Tailored roadmaps for entering the U.S. diagnostics market, grounded in regulatory, commercial, and competitive realities.
Commercial Feasibility Assessments
Rigorous analysis of market opportunity, reimbursement landscape, and competitive positioning before you commit resources.
Clinical Laboratory & Distribution Partners
Identification and qualification of the right U.S. laboratory and distribution partners for your technology and market segment.
Regulatory & Reimbursement Strategy
Coordination of FDA clearance pathways and CMS reimbursement strategy with experienced U.S. regulatory counsel.
Hands-On Commercialization Support
Active support through launch — from pilot programs and KOL engagement to sales channel development and market feedback.
Ongoing U.S. Commercial Development
Sustained partnership as your U.S. commercial presence grows — adapting strategy to market response and expanding opportunity.
Led by an Experienced Diagnostics Executive
NeoMark Ventures is led by a senior diagnostics executive with a proven track record of introducing innovative diagnostic technologies into the U.S. healthcare market. With deep relationships across clinical laboratories, health systems, and distribution networks, we bring the connections and credibility that international manufacturers need to succeed in the world's most complex diagnostics market.
"We have navigated the U.S. diagnostics market for decades — so our clients don't have to learn it from scratch."
Established track record with European, Asian, and Pacific Rim diagnostic manufacturers
Serving International Diagnostic Manufacturers
International manufacturers choose NeoMark Ventures because we combine deep U.S. market knowledge with genuine experience working across global diagnostic industries.
Europe
Germany, Switzerland, France, UK, Netherlands, and beyond
Japan
Leading innovators in immunoassay and molecular diagnostics
Taiwan
Emerging diagnostic technology manufacturers
South Korea
Rapid growth in IVD and biomarker technologies
Additional Markets
Singapore, Israel, Canada, and other international markets
Ready to Enter the U.S. Market?
Let's discuss your technology and how NeoMark Ventures can help you build a successful U.S. commercial presence.